Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (962)	7/14/1997 11:19:00 PM
From: JOHN W.	of 6136

How long has Crix been on the mkt? Resistance is not new. The failings of VX-478 is not new, I recently reccomended shorting VRTX because of the rumors I have heard. If anyone has the data discovered recently that would prompt H&Q to suggest caution about companies that produce PIs, please post it. Otherwise this could be a boom or bust situation for AGPH. If nelf's argument as a first line therapy is validated, a violent move to the upside. What new resistance evidence will take PIs out of the treatment picture, not likely. Now for the rest of the story: biz.yahoo.com Regards, John.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next